Role of contrast-enhanced ultrasound in diagnosis of pancreatic solid pseudopapillary tumor / 中华超声影像学杂志

Objective To summarize the manifestation of solid pseudopapillary tumor of the pancreas (SPTP) on ultrasound and contrast-enhanced ultrasound (CEUS) and to investigate the diagnostic value of CEUS. Methods The ultrasound and CEUS images of six patients with SPTP confirmed by pathology were reviewed. According to CEUS record,the enhanced and wash-out time,enhanced speed and degree of tumor were analyzed. Results On ultrasound, SPTP presented as solid, well-circumscribed masses, usually heterogeneous in echo texture, and some of them contained macro-calcification. On CEUS, the tumor enhanced simultaneously or slightly late compared with normal pancreatic tissues. The contrast agent washed out quickly in all tumors than in normal pancreatic tissues. The enhanced degrees were equal to or less than that of the normal pancreatic tissues. Some tumors showed capsule and septum enhancement. Conclusions The manifestation of SPTP on CEUS had some features and may be helpful for differentiation diagnosis combine with ultrasound.

Analysis of indications for adjuvant treatment in node-negative breast cancer / 中国癌症杂志

Purpose:In order to determine the indications for adjuvant treatment in node-negative breast cancer.Methods:We analyzed 233 cases of node-negative breast cancer. Results:The recurrence ratio of node-negative breast cancer was 7.3 percent. The prognosis was connected with age,menstrual history , position, diameter of tumor and pathology. Among invasive lobule cancer, GradeⅢ and lymphocyte-negative cancer, the recurrence ratio was 28 percent in patients with three factors, 16 percent in patient with two factors, 7 percent in patients with one factor.Conclusions:Node-negative breast cancer cases with high recurrence factors need adjuvant treatment.

Treatment of early-stage breast cancer with breast-conserving therapy: report of 25 cases / 中国普通外科杂志

ObjectiveTo study the rationale of breast-conserving therapy (BCT) for the treatment of early-stage breast cancer. MethodsFrom March 1994 to March 1995, 25 cases of early-stage breast cancer were treated with BCT. The indication was (1) tumor size 3.0 cm; (3) preoperative mammograms were performed in order to exclude multifocal cancer and the tumor with extensive calcification. Tumors were removed with at least 2 cm normal breast tissue margin (evaluated by frozen biopsy), and the axillary nodes were dissected in levels 1 and 2. Two weeks postoperatively patients were treated with radio-therapy to control possible microscopic residual foci. The breast cosmetic results and quality of life (QOL) were analyzed. ResultsAll cases were followed-up for an average of 64.1 months. No differences at 5 year′s survival and local recurrence were found between patients undergoing BCT and those with radical mastectomy.ConclusionThe result of early-stage breast cancer treated with breast-conserving therapy is satisfactory, this therapy is superior to radical mastectomy in terms of improving QOL under condition of strict patient selection and plan design.